Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
Martine Sautel(University Hospital of Lausanne), Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences), Wolfgang Eberlein(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Herbert Herzog(Garvan Institute of Medical Research), Helmut Wittneben(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Raquel Martínez(University Hospital of Lausanne), K Rudolf, Philippe Walker(University Hospital of Lausanne), W. Engel(University Hospital of Lausanne), Miguel Muñoz(University Hospital of Lausanne)
Cited by 94
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
Critical role for peptide YY in protein-mediated satiation and body-weight regulation
|Cell Metabolism|2006|623
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390